Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid
- 1 December 1988
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 12 (6) , 549-561
- https://doi.org/10.1007/bf00914317
Abstract
A neutral-active, Ca2+-dependent phospholipase A2 (PLA2) purified 11,000-fold from human synovial fluid (HSF) induced edema when injected into the mouse foot pad. The edema produced by HSF-PLA2 was dose-dependent and was positively correlated with the dose-dependent in vitro expression of PLA2 activity. Maximum edema was achieved within 45 min after the injection and persisted for atleast 6 h. Aristolochic acid [8-methoxy-6-nitrophenanthro(3,4-d)-1,3-dioxole-5-carboxylic acid], a major chemical component derived from various species ofAristolochia plant, produced a dose-dependent inhibition of in vitro phospholipid hydrolysis by HSF-PLA2, porcine pancreatic PLA2, snake venom (Naja naja) PLA2, and PLA2 isolated from human platelet. The sensitivity of these PLA2s to inhibition by aristolochic acid varied markedly: HSF-PLA2>N.naja PLA2>human platelet PLA2>porcine pancreatic PLA2. The inhibition of HSF-PLA2 by aristolochic acid was independent of substrate concentration (18–144ΜM and Ca2+ concentration (0.1–4.0 mM). These observations indicate that inhibition of HSF-PLA2 by aristolochic acid may result from direct interaction with the enzyme. When aristolochic acid was mixed with HSF-PLA2 and then injected into the mouse foot pad, edema was inhibited in a dose-dependent manner and was positively correlated with in vitro inhibition of PLA2 activity. Alkylation of HSF-PLA2 withp-bromophenacyl bromide concomitantly inhibited both enzyme and edema-inducing activity. These results clearly demonstrate that the neutral-active, Ca2+-dependent PLA2 isolated from human synovial fluid is proinflammatory and that catalytic activity is positively correlated with in vivo proinflammatory effects.This publication has 43 references indexed in Scilit:
- Nonspecific inhibition of enzymes by p-bromophenacyl bromide inhibition of human platelet phospholipase C and modification of sulfhydryl groupsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shockCanadian Journal of Physiology and Pharmacology, 1983
- Snake Venom Neurotoxins Related to Phospholipase A2Journal of Toxicology: Toxin Reviews, 1982
- Phospholipase A2 activity of lysosomal origin secreted by polymorphonuclear leucocytes during phagocytosis or on treatment with calciumBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Correlation of Enzymatic Activity and Anticoagulant Properties of Phospholipase A2European Journal of Biochemistry, 1980
- The release of phospholipase A2 from aggregated platelets and stimulated macrophages of sheepLife Sciences, 1980
- Modulation of purified phospholipase A2 activity from human platelets by calcium and indomethacinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
- Cytolytic and membrane-perturbing properties of lysophosphatidylcholineBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1979
- Chemical structure and biochemical significance of lysolecithins from rat liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1965
- The substrate specificity of phospholipase ABiochimica et Biophysica Acta, 1963